The White House and Senate have reached a deal for a stimulus package worth about $2 trillion, with help coming to hospitals and healthcare providers dealing with the COVID-19 outbreak.

Eleven more states are following the lead of Florida and Washington in applying for Section 1135 Medicaid waivers to be granted more flexibility in dealing with the spread of the new coronavirus, COVID-19.


CMS conducted an inspection of a nursing home based in Kirkland, Washington, the Life Care Center, considered to be the epicenter of the state’s outbreak of the new coronavirus, and is planning to inspect more nursing homes impacted by the virus.

CMS is providing exceptions from Medicare reporting requirements as well as extensions for clinicians and providers in Medicare quality reporting programs and data submission as the nation’s healthcare providers deal with the coronavirus pandemic.

The state of Washington is the second states to receive an approved Section 1135 Medicaid waiver from CMS to help deal with the COVID-19 pandemic.

As the new coronavirus, COVID-19, continues to spread across the globe and the number of infections in the U.S. rises daily, healthcare industry groups are continuing to ramp up recommendations, guidance and pressure on policymakers and regulators to ensure healthcare providers are able to respond swiftly to the crisis with flexibility.


HHS is bringing together a public-private partnership to address emergency drug packaging with a U.S.-based solution using low-cost prefilled syringes.


The Trump administration expanded telehealth benefits coverage under Medicare in order to treat patients without traveling to a healthcare facility and risk catching or spreading the new coronavirus, COVID-19.


President Trump declared a national emergency over the new coronavirus, COVID-19, on March 13, freeing up more funds to tackle the virus and respond to the crisis.

CMS has issued Frequently Asked Questions to provide more information on essential health benefits coverage of the new coronavirus, COVID-19, outbreak. 

President Trump has sent his wish list of drug pricing reform priorities to Capitol Hill.

A set of new rules that aim to improve the interoperability of healthcare records and set a string of new requirements on healthcare providers was met with mixed reactions across the industry.